AFFIMED NV by Affimed N.V. (AFMDQ) Stock Price, Quote, News & History

AFMDQOTCEM

Trade with Public

$0.000010

0.000009900.00%

Last update: Jul 20, 1:36 PM

OverviewShort Interest

Key Statistics

Open

$0.00

Volume / Avg.

5.00K / 6.80K

Day Range

$0.00 - $0.00

52 Wk Range

0.00 - 0.07

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

14.54

Recent Affimed NV News

No news found

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-76.90M

Investing Cash Flow (TTM)

19.68M

Financing Cash Flow (TTM)

714.00K

Free Cash Flow (TTM)

-77.44M

Capital Expenditure (TTM)

-534.00K

Net Change in Cash (TTM)

-56.51M

Valuation Metrics

Enterprise Value

-$13.72M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.00

PB Ratio (TTM)

0.00

Earnings Yield % (TTM)

-5181541.87%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

$1.19

Company Debt

Total Debt

$8.06M

LT Debt

$2.23M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$6.61M

Total Cash

$7.41M

Debt to Equity

0.75

Issuance of Debt (TTM)

-$6.61M

Repayment of Debt (TTM)

-$6.61M

Key Statistics

Open

$0.00

Volume / Avg.

5.00K / 6.80K

Day Range

$0.00 - $0.00

52 Wk Range

0.00 - 0.07

Market Cap

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

14.54

About

Sector

Health Care

Industry

Biotechnology

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach t...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy AFFIMED NV by Affimed N.V. (AFMDQ) stock?

You can purchase shares of AFFIMED NV by Affimed N.V. (OTCEM:AFMDQ) through any online brokerage.

View our list of the best stock brokerages

Who are AFFIMED NV by Affimed N.V. (AFMDQ) competitors?

There are no as such competitors for AFFIMED NV by Affimed N.V..

What is the forecast, or price target, for AFFIMED NV by Affimed N.V. (AFMDQ) stock?

There is no analysis for AFFIMED NV by Affimed N.V. to provide a consensus price target.

What is the current price for AFFIMED NV by Affimed N.V. (AFMDQ)?

The stock price for AFFIMED NV by Affimed N.V. (OTCEM: AFMDQ) is $0.00001 last updated July 20, 2026 at 1:36 PM EDT.

Does AFFIMED NV by Affimed N.V. (AFMDQ) pay a dividend?

There are no upcoming dividends for AFFIMED NV by Affimed N.V..

When is AFFIMED NV by Affimed N.V. (OTCEM:AFMDQ) reporting earnings?

AFFIMED NV by Affimed N.V. does not have any upcoming earnings scheduled.

Is AFFIMED NV by Affimed N.V. (AFMDQ) going to split?

There is no upcoming split for AFFIMED NV by Affimed N.V..

What sector and industry does AFFIMED NV by Affimed N.V. (AFMDQ) operate in?

AFFIMED NV by Affimed N.V. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.